. 2021 Sep 1;38(5):287–295. doi: 10.5152/balkanmedj.2021.20086
Content of this journal is licensed under a Table 3.
EGFR, ALK, ROS, PD-L1 Positivity Rate According to Cytological and Histological Specimen Subgroups
| Molecular Test | No. Histology (%) | No. Cytology (%) | P |
|---|---|---|---|
| EGFR positivity | 8 (9.0%) | 1 (2.5%) | .181 |
| ALK positivity | 7(7.9%) | 4 (9.8%) | .719 |
| ROS1 positivity | 1 (1.4%) | 1 (2.9%) | .591 |
| PD-L1 positivity | 80 (54.4%) | 25 (41.0%) | .078 |
EGFR, epidermal growth factor receptor; ALK, anaplastic lymphoma tyrosine kinase gene; ROS1, proto-oncogene tyrosine-protein kinase 1 ROS; PD-L, programmed cell death protein ligand-1.